News & HighlightsNews
The nutrient that cancer cells crave
Starving cancer cells of a key amino acid could potentially render tumors more vulnerable to the body’s natural immune response.
A unique window into "original antigenic sin"
The body's first blush with a pathogen shapes how it will respond to vaccines. New evidence clarifies how this phenomenon works, mechanistically.
How the body's B cell academy ensures a diverse immune response
A diverse immune response hinges on naive B cells mingling with high affinity ones in the late-stage germinal center. Whether that helps or hinders, however, depends on the virus.
Why older fathers pass on more genetic mutations to their offspring
It's not just the number of mutations that matters. It's the failure to fix them too.
Solving a crucial bottleneck in drug discovery
A novel method reduces the time required to identify novel antibiotic-producing DNA from weeks to days.
When the body's B cell training grounds stay open after hours
While most germinal centers shut down after a few weeks, some stay in business for more than six months. A new study helps explain why.
Intriguing science discoveries of 2022
Breakthroughs in genetics, biochemistry, neuroscience, infectious disease, and drug development were a few of the year's highlights.
How a cell's mitochondria make their own protein factories
The findings shed a rare light on mitoribosomes, the unique ribosomes found within the cell's mitochondria.
How antibody therapy impacts COVID vaccines
People who receive monoclonal antibodies before vaccines may benefit from increased coverage, due to antibody feedback inhibition.
Research on rare genetic disease sheds light on a common head and neck cancer
Patients with Fanconi anemia have an elevated risk for squamous cell carcinoma, a highly aggressive head-and-neck cancer. New findings pinpoint the mechanisms linking the two conditions, and also shed new light on how smoking or drinking may elevate anyone’s cancer risk.
View
View